Results 101 to 110 of about 7,888,061 (295)

Cyber loss model risk translates to premium mispricing and risk sensitivity. [PDF]

open access: yesGeneva Pap Risk Insur Issues Pract, 2023
Peters GW   +5 more
europepmc   +1 more source

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego   +10 more
wiley   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman   +7 more
wiley   +1 more source

Health Behaviours in Scaffold Use Risk Assessment Model – SURAM

open access: yesAnnals of Agricultural and Environmental Medicine, 2019
Introduction Problems concerning occupational safety and health are commonly found in the construction industry, including falling materials, tools or people from a height, stepping on objects, and injuries caused by hand tools.
Hubert Bojar   +4 more
doaj   +1 more source

Prediction Model Risk-of-Bias Assessment Tool for coronary artery lesions in Kawasaki disease. [PDF]

open access: yesFront Cardiovasc Med, 2022
Huang H   +14 more
europepmc   +1 more source

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Treatment‐associated hepatotoxicity (TAH) is a common complication of pediatric acute lymphoblastic leukemia (ALL) treatment, but genetic risk factors remain poorly understood. We evaluated the SOD2 rs4880 variant in 544 children with ALL at Texas Children's Hospital. After adjusting for demographic and clinical covariates, the rs4880 C allele
Emily J. Mason   +14 more
wiley   +1 more source

Complex Model of Risk Assessment of Industrial Processes Mopori

open access: yesCommunications, 2013
Modern day society wants to create optimal living conditions for its citizens and to ensure constant sustainable development. This objective cannot be achieved without reaching the required level of perceived security in complex.
Katarina Holla   +3 more
doaj   +1 more source

Is jump risk priced? - What we can (and cannot) learn from option hedging errors : [This version: November 26, 2004] [PDF]

open access: yes, 2004
When options are traded, one can use their prices and price changes to draw inference about the set of risk factors and their risk premia. We analyze tests for the existence and the sign of the market prices of jump risk that are based on option hedging ...
Branger, Nicole, Schlag, Christian
core  

Risk measure modelling [PDF]

open access: yesInterdisciplinary Management Research, 2007
As a phenomenon, risk represents a latent quantity of money or equivalent values needed as a guarantee. We would like to model in some essential way the approach to potential loss caused by various agents. If the interest focuses on security, it is necessary to determine a limit.
openaire   +1 more source

Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies. [PDF]

open access: yesCancers (Basel), 2022
Kaiser I   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy